Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

FBIO

Fortress Biotech (FBIO)

Fortress Biotech Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBIO
DataHoraFonteTítuloCódigoCompanhia
21/06/202417:01GlobeNewswire Inc.Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
20/06/202409:30GlobeNewswire Inc.Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:FBIOFortress Biotech Inc
20/06/202409:00GlobeNewswire Inc.Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:FBIOFortress Biotech Inc
17/06/202409:30GlobeNewswire Inc.Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T TherapyNASDAQ:FBIOFortress Biotech Inc
16/05/202409:30GlobeNewswire Inc.Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)NASDAQ:FBIOFortress Biotech Inc
16/05/202409:00GlobeNewswire Inc.Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
15/05/202417:15GlobeNewswire Inc.Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
15/05/202417:01GlobeNewswire Inc.Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:FBIOFortress Biotech Inc
15/05/202409:30GlobeNewswire Inc.Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
14/05/202409:30GlobeNewswire Inc.Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver TransplantationNASDAQ:FBIOFortress Biotech Inc
13/05/202417:01GlobeNewswire Inc.Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
07/05/202409:30GlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:FBIOFortress Biotech Inc
02/05/202417:01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
01/05/202417:01GlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:FBIOFortress Biotech Inc
29/04/202421:00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:FBIOFortress Biotech Inc
29/04/202409:00GlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
25/04/202409:30GlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:FBIOFortress Biotech Inc
24/04/202408:30GlobeNewswire Inc.Avenue Therapeutics Announces Reverse Stock SplitNASDAQ:FBIOFortress Biotech Inc
28/03/202417:05GlobeNewswire Inc.Fortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
28/03/202410:00GlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesNASDAQ:FBIOFortress Biotech Inc
25/03/202409:30GlobeNewswire Inc.Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024NASDAQ:FBIOFortress Biotech Inc
21/03/202417:01GlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
18/03/202417:05GlobeNewswire Inc.Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:FBIOFortress Biotech Inc
18/03/202409:30GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:FBIOFortress Biotech Inc
15/03/202409:30GlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:FBIOFortress Biotech Inc
15/03/202409:15GlobeNewswire Inc.Avenue Therapeutics Receives Positive Listing Determination from NasdaqNASDAQ:FBIOFortress Biotech Inc
13/03/202409:30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
12/03/202409:30GlobeNewswire Inc.Fortress Biotech to Participate in 36th Annual ROTH ConferenceNASDAQ:FBIOFortress Biotech Inc
11/03/202409:30GlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:FBIOFortress Biotech Inc
11/03/202409:00GlobeNewswire Inc.Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual MeetingNASDAQ:FBIOFortress Biotech Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBIO